News

MOST VIEWED

Vintage-style illustration of a cracked, dry eye, with a research graph and a scientist examining a sample
Business

Amgen’s Sjögren’s Drug Dazodalibep Clears Phase III Trial

It tamed systemic disease activity, but what did it do for the ocular surface? The answer’s murky.  Amgen (California, United States) has reported positive Phase III results for dazodalibep, its investigational treatment for Sjögren’s disease, a condition with no FDA-approved disease-specific therapy in the U.S. The drug goes after the immune activity behind the disease...
Illustration of an FDA warning featuring a weight-loss injection pen, a person measuring their waist, a warning sign, and a woman covering her eyes against a beige background.
Clinical Trials

FDA Puts All GLP-1 Drugs on NAION Watch

Regulators want a warning, neuro-ophthalmologists say don’t panic, and the mechanism is anyone’s guess.  The U.S. Food and Drug Administration (FDA) is requiring safety labeling changes for all glucagon-like peptide-1 receptor agonists (GLP-1 RAs) over a potential increased risk of nonarteritic anterior ischemic optic neuropathy (NAION), giving the optic nerve a spot on the labels...
An illustration of AEYE Health’s eye-shaped mascot on a tablet beside a silver trophy, celebrating its Prix Galien USA Award
Tech and Pharma

Diabetic Retinopathy Screening in 60 Seconds Earns Top Digital Health Award

Autonomous AI is reading retinas in primary care. Here’s the evidence behind the winning screen.  AEYE Health (New York, United States) has caught the judges’ eye. The company’s AEYE-DS, an FDA-cleared autonomous AI system for diabetic retinopathy (DR) screening, has won the 2026 Prix Galien USA Award for Best Digital Health Solution. AEYE Health announces...
Illustration of an older man and woman dancing beneath three eye symbols and a male-female equality sign, with an age scale below
Research & Evidence

Who Gets Glaucoma Diagnosed First? Age, Sex and Hormones Offer Clues

Women under 55 got there sooner. Women on estrogen got there later. The VA data has a twist or two. Age has long been the headline risk factor for open-angle glaucoma (OAG), but when it comes to the timing of diagnosis, it may not be working alone. Among U.S. veterans, women younger than 55 were...
A woman reading a book, with a magnifying glass and newspaper clippings on a yellow background.
Tech and Pharma

Eyedaptic Launches Eva, an Agentic AI Assistant for Low Vision Smart Glasses in AMD

Smart glasses that take a hint, not just a command. But is the clinical evidence keeping pace?  Smart glasses are learning to take a hint. U.S.-based Eyedaptic has launched Eva (Eyedaptic Visual Assistant), an agentic artificial intelligence (AI) assistant for its EYE7 vision-enhancing smart glasses, designed for people with age-related macular degeneration (AMD) and other...
global_summit thumbnail (1)
Visionary Voices

44 Countries Commit Over US$1 Billion to Eye Care in Global Summit 

More than one billion people worldwide live with vision loss that could be prevented or treated. This week, governments put a fitting number on the table. At the inaugural Global Summit for Eye Health, delegations from 44 countries, including 13 heads of state and government, announced more than US$1 billion in domestic funding to expand...
Illustration of a woman with a teardrop below her eye, alongside gloved hands holding eye drops and a medical shield, with the Bausch + Lomb logo
Dry Eye

Bausch + Lomb Survey Exposes the Dry Eye Diagnosis Gap

Plenty of people with dry eye keep a bottle of drops handy. Fewer keep an appointment.  A new multinational survey from Bausch + Lomb (Vaughan, Ontario) found that self-reported dry eye symptoms outpaced reported professional diagnoses, and many respondents were managing persistent symptoms on their own, even after consulting a healthcare professional. Bausch + Lomb...
MM_IAPB ig_thumbnail
Beyond the Clinic

Eye Health Earns a Spot on the CHOGM 2026 Agenda

Commonwealth leaders are swinging bats and chasing billions. Eye health wants in on the action. Leaders from all 56 Commonwealth countries meet in St John’s, Antigua and Barbuda, from November 1 to 4 for the 28th Commonwealth Heads of Government Meeting (CHOGM), and eye health is one of just four side events on the program.*...

No entries were found for this taxonomy term.